Interactions between Xenobiotics and DME (XEOTIC)
|
Natural Product(s), Extract(s) or Medicine(s) |
Natural Product |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
Topaquinone |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO01113
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Natural Product |
DME Modulation |
Topaquinone induces the drug-metabolizing activity of DME AOC1 |
[1] |
Pharmaceutical Agent(s) |
Approved/Marketed Drug |
Click to Show/Hide the Full List of Xenobiotics: 5 Xenobiotics
|
Acetaminophen |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00217
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Acetaminophen inhibits the expression of DME AOC1 |
[2] |
Amiloride hydrochloride |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00276
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Drug Approved by US FDA |
DME Modulation |
Amiloride hydrochloride inhibits the drug-metabolizing activity of DME AOC1 |
[3] |
Copper |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00834
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Drug Approved by US FDA |
DME Modulation |
Copper induces the drug-metabolizing activity of DME AOC1 |
[1] |
Cyclosporine |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00241
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Cyclosporine inhibits the expression of DME AOC1 |
[4] |
Theophylline |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00005
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Theophylline inhibits the expression of DME AOC1 |
[5] |
Drug in Phase 2 Clinical Trial |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
Pimagedine |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00577
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Highest Clinical Status: Phase 2 |
DME Modulation |
Pimagedine inhibits the drug-metabolizing activity of DME AOC1 (Ki = 0.14 microM) |
[3] |
Drug in Phase 1 Clinical Trial |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
Sodium arsenite |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00632
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Highest Clinical Status: Phase 1 |
DME Modulation |
Sodium arsenite inhibits the expression of DME AOC1 |
[6] |
Investigative Agent |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
Ethyl isopropylamiloride |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO01293
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Investigative Agent |
DME Modulation |
Ethyl isopropylamiloride inhibits the drug-metabolizing activity of DME AOC1 |
[3] |
|
|
|
|
|
|